Article info

Download PDFPDF
Original article
Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn’s disease: the LIR!C Trial

Authors

  1. Correspondence to Dr Willem A Bemelman, Department of Surgery, Amsterdam UMC, University of Amsterdam, Amsterdam 1012 WX, The Netherlands; w.a.bemelman{at}amc.uva.nl
View Full Text

Citation

de Groof EJ, Stevens TW, Eshuis EJ on behalf of the LIR!C study group, et al
Cost-effectiveness of laparoscopic ileocaecal resection versus infliximab treatment of terminal ileitis in Crohn’s disease: the LIR!C Trial

Publication history

  • Received September 6, 2018
  • Revised December 27, 2018
  • Accepted January 4, 2019
  • First published February 1, 2019.

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.